A Prolactin (PRL) hyper-response to TRH was described in IDDM children suggesting an alterated dopaminergic control. N o changes in plasma renin activity (PRA) and aldosterone (A) plasma levels after Domperidone (DMP), a dopamine antagonist, uere reported in adult healthy subjects. PRL, PRA and A levels uere measured before and after i.v. DMP injection (10 mgl1.73 n2) in 10 IDDM insulin treated, normotensive, 2 hrs-recumbent, uell controlled outpatients (10 to 19 years old).
Hypergastrinemia ( f G), hypopepsinogenemia ( 4 PG1) and gastric parietal cells autoantibodies (PCA) are considered as markers of atrophic gastritis .hich is a common complication in diabetic adults.
We investigated 3 2 insulin treated, non ketotic IDDM children (5 to 18 yrs old). without any gastro-intestinal symptom, uith diabetes lasting from 2 to 130 mos. ? G. J . PG1 and PCA have been found (single or in association) in 7/32 subjects (21,8%; 4 F-3 M).
In 5 of them a multiple perendoscopic gastric biopsy shoved the histological pattern of a chronic superficial gastritis of antral and fundic aucosa in 2 females uithout correlation uith a duration of diabetes.
In conclusion:
-A chronic superficial gastritis may be present, in single cases of IDDH. yet in the pediatric age. It may be clinically silent but t G .( PGI and PCA seem to be useful indicators.
-The pathogenesis and the possible relationship vith the atrophic gastritis of diabetic adult are still to be clarified. Opiate receptors seem to play a role in the maintenance o f glucose homeostasis. Both 8-endorphin (8-EP) and opiate antagonist drugs may modulate the endocrine pancreas secretions. Considering the changes of circulating B-EP through puberty, ue studied B-EP plasma levels in IDDM patients. Since IDDM children are characterized by LH/FSH aspecific rises after TRH injection, ue also evaluated the B-EP pattern after TRH and LHRH administration. In 4 6 IDDM patients (7-18 years).under insulin treatment, blood sample was collected in basal condition and in 16 of them TRH (200 mcg, i.v.) and LHRH (50 mcg, i.v.) tests uere performed. B-EP levels uere measured after silicic acid extraction and Sephadex G-75 column cromatography, by RIA utilizing material provided by C.H. Li (San Francisco). Basal B-EP levels in 1DDM children uere similar to age-matched controls; no correlation was found uith the duration and the metabolic control o f the disease. LHRH stimulated B-EP release between 60' and 120' ( p~0 . 0 5 ) (from 5.8~1.2 fmol/ml to 1 3~1 . 8 M+SD) -in about 30% of the patients, namely those at more enhanced stage of puberty. Similary TRH induced 8-EP increase between 90' and 120' (p<0.01) in the 45% of the patients (from 5.5+1.2 to 13.5~1.4). No B-EP changes uas observed in healthy controls under similar experimental conditions. These data suggest: l)lDDH does not seem to influence plasma 8-EP levels, at least in uell controlled subjects; 2) the aspecific pituitary responses to hypothalamic releasing-hormones previously described in IDDM patients, involve also 8-EP release.
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Animal experiments have documented a l t e r a t i o n s i n h e p a t i c drug metabolism i n d i a b e t i c r a t s . I n a d d i t i o n t o a b n o r m a l i t i e s i n g l y c o s y l a t i o n of hemoglobin o t h e r heme p r o t e i n s such as c y t ochrome P-450 m i g h t a l s o be expected t o be a l t e r e d .
We r e p o r t h e r e changes i n cytochrome P-450 dependent d r u g m e t a b o l i z i n g a c t i v i t y i n c h i l d r e n w i t h IDDY4. We have s t u d i e d a n t i p y r i n e (AP) k i n e t i c s i n 8 c h i l d r e n (age 10-22 y r ) w i t h IDDI-1 o f a t l e a s t 3 months d u r a t i o n who were a l l i n poor c o n t r o l as d e f i n e d by Hgb A1 l e v e l s . L i v e r f u n c t i o n t e s t s and r e n a l f u n c t i o n were normal. I n s u l i n dose ranged between 0.5-1 U/kg. AP ( t e I n t h r e e IDDEl p a t i e n t s w i t h n e a r n l Hgb A1 l e v e l s (6.8,7.1 ,8%) AP t 4 was n l when compared t o age matched c o n t r o l s (8.1 ,9.2,8hr) as was AP clearance. Conclusion: I n p o o r l y c o n t r o l l e d IDDM h e p a t i c d r u g metabolism may be a l t e r e d : AP c l e a r a n c e i s increased, AP t% i s shortened. I n w e l l c o n t r o l l e d IDDH a n t i p y r i n e drug metabolism appears t o be n l . These f
i n d i n g s p r o v i d e a n o t h e r cogent argument f o r t i g h t m e t a b o l i c c o n t r o l i n youngsters w i t h IDDM.
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GROWTH HORMONE RECEPTORS AND THE ONSET OF HYPERINSULINEMIA I N THE OBESE ZUCKER RAT. Growth hormone (GH) r e l e a s e , h e p a t i c GH and i n s u l i n r e c e p t o r s have been s t u d i e d i n t h e g e n e t i c a l l y obese male Zucker ( f a / f a ) r a t . I n c h r o n i c a l l y cannulated 14 week-old r a t s , t h e p u l s a t i l e GH s e c r e t i o n i s suppressed i n obese r a t s and t h e GH p i t u i t a r y c o n t e n t i s 2 t i n e s lower i n f a / f a t h a n i n l e a n animals. A t 2, 3 and 5 weeks o f age, no d i f f e r e n c e i n t h e p i t u i t a r y GH c o n t e n t i s found i n t h e two groups. A t 23 days o f age, f a / f a r a t s have a t w o -f o l d i n c r e a s e i n t h e i r plasma i n s u l i n l e v e l ; t h e s p e c if i c b i n d i n g o f 12
'1-hGH t o l i v e r membranes o f obese male r a t s as compared t o l e a n l i t t e r m a t e s i s increased, 2.8 t i m e s i n plasma membranes, 1.4 t i m e s i n G o l g i f r a c t i o n s . A t 5, 11 and 14 weeks o f age, plasma i n s u l i n i s markedly e l e v a t e d i n obese r a t s and t h e l e v e l o f GH r e c e p t o r s i s h i g h e r i n a l l l i v e r s u b f r a ct i o n s o f obese r a t s as compared t o l e a n r a t s . A f t e r t h e 1 1 t h week, h y p e r i n s u l i n e m i a i s a s s o c i a t e d w i t h a decrease b i n d i n g o f i n s u l i n t o plasma membranes and t o microsomal f r a c t i o n s o f obese r a t s . Before t h e i n c r e a s e i n plasma i n s u l i n appears, a t 16 days o f age, no d i f f e r e n c e i n t h e l e v e l o f GH r e c e p t o r s e x i s t s i n plasma membranes and G o l g i f r a c t i o n s o f f a / f a r a t s and of t h e i r l e a n l i t t e r m a t e s . The i n c r e a s e i n GH b i n d i n g observed i n obese niale r a t s i s simultaneous w i t h t h e onset o f h y p e r i n s u l i n e m i a . . We now r e p o r t t h a t t h e C l a s s I 1 gene prod u c t s (coded by t h e RT1.B ard RT1D l o c i ) of t h e BB s t r a i n and t h e DM s t r a i n s derived from they do not d i f f e r from t h e C l a s s I 1 p r o d u c t s found i n t h e non-DM inbred W i s t a r F u r t h r a t (RT1.AuBuDu). A c r o s s between t h e homozygous u/u D M r a t and r a t s of t h e inbred PVG.RE(RT1.AaBuDu) s t r a i n r e s u l t s i n F2 DM animals typing u/u,u/a, and a/a a t t h e RT1.A locus. Since a l l animals i n these crosses a r e hunozygous u/u a t t h e RT1.B and D l o c i , t h e r e s u l t s suggest t h a t (1) C l a s s I MHC gene products a r e n o t n e c e s s a r y f o r DM and (2) RT1 B and D g e n e s ( o r genes c l o s e l y l i n k e d t o them) from n o n -d i a b e t i c inbred s t r a i n s bearing t h e u haplotype can, i n conjunction with other genetic o r environenntal factors, confer s u s c e p t i b i l i t y t o DM. I n such s u s c e p t i b l e r a t s increased nw$ers of peripheral blood lymphoc y t e s c a p a b l e of b i n d i n g a mouse a s c i t e s p r o t e i n p r o v i d e a marker of conA unresponsiveness and a r e a more r e l i a b l e pred i c t o r of DM s u s c e p t i b i l i t y t h a n enumerations of lymphocyte subsets by monoclonal antibody staining.
